This is a $1,423,503.00 definitive, firm-fixed-price contract awarded by the Food and Drug Administration (FDA) to the Colorado Department of Public Health & Environment (CDPHE) to conduct inspections of certified non-federal mammography facilities in Colorado. The contract is not set aside for any specific type of business. The contract supports the FDA's Mammography Quality Standards Act (MQSA) program, which requires regular inspections of mammography facilities to ensure compliance...
This contract was awarded by the Department of Health and Human Services' Food and Drug Administration to the Colorado Department of Public Health & Environment, a state government entity, to provide mammography equipment inspections in Denver, Colorado. The contract is a definitive, firm-fixed price award with a potential value of $1,038,055.94 and a completion date of June 30, 2022. The contract does not have a set-aside designation. As a state health department, the Colorado Department of...
This is a definitive, firm-fixed-price federal contract award for $13,120,419.42 to the California Department of Public Health (CDPH), a division of the State of California Controllers Office, by the Food and Drug Administration (FDA). The contract is for the Mammography Quality Standards Act (MQSA) Program, a civilian program without a set-aside designation. CDPH, as a prime contractor, has a long history of providing specialized public health services to various federal agencies, including the...
This $1,177,784.02 firm fixed-price federal contract was awarded by the Food and Drug Administration (FDA) to the Washington State Department of Health to conduct inspections of certified non-federal mammography facilities and ensure compliance with quality standards under the Mammography Quality Standards Act (MQSA). The contract has an ultimate completion date of July 21, 2027. This sole source contract was awarded without a set-aside. The Washington State Department of Health, as a state...
This is a delivery order awarded by the Food and Drug Administration (FDA) to the Colorado Department of Public Health & Environment (CDPHE), a U.S. state government entity, for a task order under a larger contract. The task order is valued at $1,525,072.40 and runs from May 30, 2025 to May 29, 2026, with a final completion date of September 29, 2029. The contract is a Cost No Fee type and does not have a set-aside designation. This task order is part of a broader $1,043,040.14 FDA...
The U.S. Food and Drug Administration (FDA) awarded a $262,548.81 firm fixed-price contract to the South Dakota Department of Health (SD DOH) to conduct inspections of certified non-federal mammography facilities and ensure compliance with quality standards under the Mammography Quality Standards Act (MQSA). This contract, awarded on June 30, 2022, has an ultimate completion date of January 1, 2028. The contract was issued as a sole-source award, as the state government organization is the...
This is a federal contract award from the Department of Health and Human Services Food and Drug Administration (FDA) to the Colorado Department of Public Health & Environment (CDPHE), a state government entity. The contract, with a potential value of $3,293,273.69, is for the COLORADO CTP INSPECTION PROGRAM and has a completion date of September 29, 2020. It is a definitive contract with a cost no fee pricing type, and there is no set-aside designation. The CDPHE, as a subrecipient, has also...
This is a $370,094.84 firm fixed price definitive contract awarded by the Food and Drug Administration (FDA) to the State of Utah Department of Environmental Quality (UDEQ) to conduct inspections of certified non-federal mammography facilities. The contract supports the Mammography Quality Standards Act (MQSA) program, which requires regular inspections to ensure compliance with quality standards. As a state government agency, UDEQ has the legal authority and experienced personnel necessary to...
This is a $2,472,203.55 firm-fixed-price definitive contract awarded by the U.S. Food and Drug Administration (FDA) to the Michigan Department of Labor and Economic Opportunity (MDLEO), doing business as the Talent Investment Agency. The contract is for implementing the Mammography Quality Standards Act (MQSA), which provides regulatory oversight to ensure the quality and safety of mammography facilities. The contract has an ultimate completion date of March 22, 2028 and was awarded on September...
This is a sole-source federal contract awarded by the Food and Drug Administration (FDA) to the State of North Carolina Department of Health & Human Services (NC DHHS) to conduct inspections of certified non-federal mammography facilities and ensure compliance with quality standards under the Mammography Quality Standards Act (MQSA). The contract has a ceiling value of $2,548,801.45 and a period of performance ending on September 29, 2027. This is a Firm Fixed Price contract with no...